Detailled Information

Name of the Instrument/Tool Rheumatoid Arthritis Foot Disease Activity Index 5 (RADAI-F5)
First Description

Hoque A, Gallagher K, McEntegart A, Porter D, Steultjens M, Woodburn J, Hendry GJ. Measuring Inflammatory Foot Disease in Rheumatoid Arthritis: Development and Validation of the Rheumatoid Arthritis Foot Disease Activity Index-5. Arthritis Care Res (Hoboken). 2021 Sep;73(9):1290-1299. doi: 10.1002/acr.24259. Epub 2021 Aug 13. PMID: 32433810.

Year 2021
Domains
Concept of constructs Disease activity, Foot health
Population/Disease Disease specific
Originally developed for Rheumatoid Arthritis (RA)
Other rheumatic diseases
where can be applied (only if validated)
---
Additional population with no rheumatic diseases No
Language: Originally published in English
Available in Language ---
REFERENCE IDENTIFICATION
Author/s Hoque A, Gallagher K, McEntegart A, Porter D, Steultjens M, Woodburn J, Hendry GJ.
Title Measuring Inflammatory Foot Disease in Rheumatoid Arthritis: Development and Validation of the Rheumatoid Arthritis Foot Disease Activity Index-5.
Journal Arthritis Care Res (Hoboken).
Year 2021
Vol 73
Num 9
Pages 1290-99
Country UK
Language English
Other references of interest
Link https://pubmed.ncbi.nlm.nih.gov/7779122/
Brief Description

A self- administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research: psychometric properties and correlation with parameters of disease activity.

Link https://pubmed.ncbi.nlm.nih.gov/18484698/
Brief Description

Patient- centred rheumatoid arthritis disease activity assessment by a modi-fied RADAI

Instrument/Tool Translations References
No other References.
DEVELOPER CONTACT INFORMATION
Correspondence to Gordon J. Hendry, PhD
E-Mail gordon.hendry@gcu.ac.uk.
Address School of Health and Life Sciences, Glasgow Caledonian University, Cowcaddens Road, Glasgow, UK.
Website https://www.gcu.ac.uk/hls/research/researchgroups/musculoskeletalhealth/radai-f5/
Available ---
Links ---
DESCRIPTION OF THE INSTRUMENT
Type Of Measure Questionnaire
Brief Description

The design and content of the Rheumatoid Arthritis Foot Disease Activity Index– 5 (RADAI- F5) was derived from the mRADAI- 5, a 5- item patient-reported outcome measure for the self- report of global disease activity. 

The RADAI- F5 was developed by editing the mRADAI- 5 with an opening statement: “Thinking only of your feet,” and editing the original questions to subsequently read as follows: “How active was your arthritis in your feet over the last 6 months?” (0 = completely inactive to 10 = extremely active); “How active is your foot arthritis today with respect to joint tenderness and swelling?” (0 = completely inactive to 10 = extremely active); “How severe is your arthritis pain in your feet today?” (0 = no pain to 10 = unbearable pain); “How would you describe your general foot health today?” (0 = very good to 10 = very bad); “Did you experience foot joint stiffness on awakening yesterday morning? If yes, how long was this stiffness in your feet?” (0 = no stiffness to 10 = stiffness the whole day).

It was developed for rheumatologists and health professionals for measurement and monitoring of foot disease activity in people with rheumatoid arthritis in clinical practice, and/or researchers with an interest in the foot.

Number of Items 5
Range 0-10
Responses options/scale No
Developed for Clinical practice, Research
PRACTICAL APPLICATION
Method of administration Self-administered
Recommendations to score

The RADAI- F5 is completed in a numerical rating scale format from 0 to 10 and scored by an average summary score ranging 0– 10.

Score Interpretation Scored by an average summary score ranging from 0 to 10. Higher scores indicate higher foot disease activity.
Cut-off points Remission state is defined as a RADAI-F5 score ranging from 0 to 1.0; >1 to 3.6 for mild disease activity, >3.6 to 5.7 for moderate disease activity, and >5.7 to 10 for high disease activity.
Cut-off points applied to Research, Routine care
Smallest detectable change if described The 95% smallest detectable change value was estimated as 2.69, representing 26.9% of the RADAI-F5 scale maximum range, meaning that we can be 95% confident that a change score of 2.69 or more is a true change.
Smallest detectable change applied to Routine care, Research
Completion time by the patient 5 minutes
Scoring time by the assessor - minutes
Training to score Not necessary
Strengths Easy to use
Limitations ---
OTHER COMMENTS
Other Comments ---